Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2001
10/04/2001WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer
10/04/2001WO2001072458A1 Site-specific, covalent bioconjugation of proteins
10/04/2001WO2001072347A1 Agents promoting the formation of skin basement membrane, agents promoting the formation of artificial skin and process for producing artificial skin
10/04/2001WO2001072339A2 Method of treatment of conditions involving obstruction of blood flow
10/04/2001WO2001072338A1 Alprazolam inclusion complexes and pharmaceutical compositions thereof
10/04/2001WO2001072337A1 Proteins for use as carriers in conjugate vaccines
10/04/2001WO2001072336A1 Compounds for targeting
10/04/2001WO2001072323A2 Use of insulin for the treatment of cartilagenous disorders
10/04/2001WO2001072315A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract
10/04/2001WO2001072310A1 Pharmaceutical gel composition
10/04/2001WO2001072301A1 Intracorporeal medicaments for photodynamic treatment of disease
10/04/2001WO2001072300A1 Uses of metal salts to stabilize taxane-based compositions
10/04/2001WO2001072299A1 Taxane-based compositions and methods of use
10/04/2001WO2001072283A1 Cationic liposomes
10/04/2001WO2001072281A2 Microspheres for active embolization
10/04/2001WO2001072279A2 Medical emulsion for lubrication and delivery of drugs
10/04/2001WO2001072277A2 Immunotherapeutic methods and compositions
10/04/2001WO2001072264A2 Pro-liposomal encapsulated preparations (iv)
10/04/2001WO2001072144A1 Use of polyphosphate as a tooth erosion inhibitor in acidic compositions
10/04/2001WO2001044198A8 Amphiphilic quinolylpolyamines as transfer agents for biologically active macromolecules
10/04/2001WO2001024780A3 Soft gel capsule resistant to gastric juices
10/04/2001WO2001019335A3 Composition to be administered through mucous membrane
10/04/2001WO2001013957A3 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
10/04/2001WO2001013956A3 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
10/04/2001WO2001012214A3 MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a)
10/04/2001WO2001007075A3 Multi-dose erythropoietin formulations
10/04/2001WO2001005429A3 Powder particles with smooth surface for use in inhalation therapy
10/04/2001WO2001004195A8 Film coatings and film coating compositions based on polyvinyl alcohol
10/04/2001WO2001004135A3 Crosslinked dna condensate compositions and gene delivery methods
10/04/2001WO2001000244A3 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
10/04/2001WO2000053231A3 Fatty acid-anticancer conjugates and uses thereof
10/04/2001WO2000045850A9 Drug delivery vehicle
10/04/2001US20010027237 Comb copolymers for regulating cell-surface interactions
10/04/2001US20010027212 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10/04/2001US20010027203 Chemical complex comprising a pyridine carboxy derivative and an H2 histamine receptor antagonist
10/04/2001US20010027191 Soluble forms of amoxicillin and treatment of animals
10/04/2001US20010027180 GLP-2 formulations
10/04/2001US20010027177 Pharmaceutical composition containing a small or medium size peptide
10/04/2001US20010026810 Polyurethane prepolymer with polyoxyethylene, polyoxypropylene or propylene glycol; absorbtive, contours to wound site; maintains moisture for healing; may contain fungicidal, bactericidal and deodorizing additives
10/04/2001US20010026804 Compressed microparticles for dry injection
10/04/2001US20010026800 Delivering an immunogen to a preselected region of the gastrointestinal tract
10/04/2001EP1138661A1 Pulverised mannitol and process for its preparation
10/04/2001EP1138337A2 Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
10/04/2001EP1138334A2 Pretargeting methods and compounds
10/04/2001EP1138333A1 Medicinal compositions for oral use
10/04/2001EP1138322A2 Capsules comprising polymers of vinylesters and polyethers, their use and their preparation
10/04/2001EP1138321A2 Solid oral dosage forms with sustained drug release and high mechanical stability
10/04/2001EP1138320A2 Floating forms containing drug, polyvinyl acetate and polyvinyl pyrrolidone, their use and preparation
10/04/2001EP1138319A2 Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
10/04/2001EP1138314A2 Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
10/04/2001EP1138313A1 Proliposomes
10/04/2001EP1138310A1 Proliposomes
10/04/2001EP1138309A2 Dental composition based on cationically polymerisable monomers
10/04/2001EP1137805A1 Methods of facilitating vascular growth
10/04/2001EP1137762A1 Treatment of pompe's disease
10/04/2001EP1137760A1 Bleaching enzymes and detergent compositions comprising them
10/04/2001EP1137758A2 Method and composition for preserving viruses
10/04/2001EP1137671A1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
10/04/2001EP1137652A2 Conjugates comprising galactose alpha 1,3 galactosyl epitopes and methods of using same
10/04/2001EP1137442A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative
10/04/2001EP1137441A1 Ion exchange tumor targeting (iett)
10/04/2001EP1137440A1 A stable product of isohexylnaphthazarins with penta- and tetra-cyclic triterpenes
10/04/2001EP1137439A2 Stabilization of macrolides
10/04/2001EP1137434A2 New cancer treatments
10/04/2001EP1137431A1 Pharmaceutical compositions containing insulin
10/04/2001EP1137422A2 Use of human prostate cell lines in cancer treatment
10/04/2001EP1137409A2 Compositions and methods for amelioration of human female sexual dysfunction
10/04/2001EP1137407A1 The process for manufacturing formulation of topical beta blockers with improved efficacy
10/04/2001EP1137405A1 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof
10/04/2001EP1137404A2 Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations
10/04/2001EP1137403A1 Sustained release tablet containing hydrocolloid and cellulose ether
10/04/2001EP1137402A1 Phospholipid compositions
10/04/2001EP1137401A1 Administration of neurotrophic agents to the central nervous system
10/04/2001EP1137400A1 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period toff, verfahren zu seiner herstellung und anlage zur durchfuhrung des verfahrens
10/04/2001EP1137399A2 Improvements in or relating to powders
10/04/2001EP1137398A1 Pharmaceutical preparation for inhalation of an opioid
10/04/2001EP1137373A1 Biocompatible crosslinked polymers
10/04/2001EP0950408B1 Oily patches for external use containing diclofenac sodium
10/04/2001EP0748342B1 Block and graft copolymers and methods relating thereto
10/04/2001EP0682524B1 Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
10/04/2001EP0674646B1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
10/04/2001EP0529002B1 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes
10/04/2001DE10016323A1 Dentalwerkstoff auf Basis von kationisch polymerisierbaren Monomeren Dental materials based on cationically polymerizable monomers
10/04/2001DE10014588A1 Sustained-release oral dosage form that floats in gastric fluid includes a blend of polyvinyl acetate and polyvinylpyrrolidone
10/04/2001DE10012908A1 Stabilisierte übersättigte transdermale therapeutische Matrixsysteme Stabilized supersaturated matrix transdermal therapeutic systems
10/04/2001CA2404756A1 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof
10/04/2001CA2404432A1 Compositions and methods for identifying and targeting cancer cells
10/04/2001CA2404428A1 High specificity marker detection
10/04/2001CA2404374A1 Use of metal salts to stabilize taxane-based compositions
10/04/2001CA2404370A1 Taxane-based compositions and methods of use
10/04/2001CA2404147A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract
10/04/2001CA2404082A1 Site-specific, covalent bioconjugation of proteins
10/04/2001CA2403993A1 Proteins for use as carriers in conjugate vaccines
10/04/2001CA2402613A1 Cationic liposomes
10/04/2001CA2402453A1 Compounds for targeting
10/04/2001CA2402187A1 Intracorporeal medicaments comprising halogenated xanthene for photodynamic treatment of disease
10/03/2001CN1315966A High-affinity antibodies
10/03/2001CN1315936A Compounds and compositions for delivering active agents
10/03/2001CN1315868A Pharmaceutical formulations for IGF/IGFBP
10/03/2001CN1315865A Stabilized pharmaceutical Composition in lyophilized form
1 ... 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 ... 1712